Skip to main content
Clinical Trials/NCT04145921
NCT04145921CompletedNot Applicable

Effectiveness of Fast-track Clinical Pathway on Minimally-invasive Total Hip Arthroplasty Surgery in NTUH

National Taiwan University Hospital0 sites75 target enrollmentStarted: January 7, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Primary Endpoint
post-operative length of hospital stay

Study Overview

Brief Summary

The objective of this study was to evaluate the effects of an enhanced recovery after surgery (ERAS) pathway incorporated with pre-operative physical therapy and education on immediate and short-term outcomes of minimally-invasive surgery of total hip arthroplasty (MIS-THA). We hypothesized that this ERAS pathway can shorten post-operative length of hospital stay and ensure same-day independent mobilization in MIS-THA. The first specific aim was to compare primary immediate outcomes, including post-operative length of hospital stay and the rate of same-day independent mobilization, between ERAS for MIS-THA patients and conventional MIS-THA patients. The second aim was to compare other immediate outcomes, including post-operative pain scores, analgesics usage, the rate of blood transfusion and post-operative nausea and vomiting (PONV), between the two groups of patients. Third, we aimed to compare short-term outcomes, including post-operative 1-year Harris hip score, Oxford hip score and EQ-5D index of quality of life, between the two groups of patients. We also compared hospital cost and profit between the two groups of patients. Moreover, we identified the factors affecting post-operative length of hospital stay in ERAS for MIS-THA patients.

Detailed Description

Study subjects:

We conducted a prospective comparative study to investigate 50 patients receiving an ERAS pathway incorporated with pre-operative physical therapy and education for MIS-THA and 25 patients receiving conventional MIS-THA. We included the patients with advanced osteonecrosis of femoral head or hip osteoarthritis receiving unilateral primary MIS-THA performed by the same surgeon at the same hospital. We excluded patients with renal or hepatic function impairment which precluded multimodal pain control. However, we did not preselect patients with younger age or better activity level. This study was approved by the Institutional Review Board at National Taiwan University Hospital. Written informed consent was obtained from all patients.

ERAS for MIS-THA versus conventional MIS-THA:

In this study, ERAS for MIS-THA was defined as the ERAS pathway incorporated with pre-operative short-term physical therapy and education for MIS-THA. On the other hand, conventional MIS-THA in this study was defined as the conventional pathway without pre-operative physical therapy and education for MIS-THA. Both of ERAS for MIS-THA and conventional MIS-THA comprised the same MIS-THA techniques, multimodal pain control, standardized volume management and PONV prophylaxis, deep vein thrombosis prophylaxis and post-operative rehabilitation program.

Pre-operative physical therapy and education:

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with advanced osteonecrosis of femoral head or hip osteoarthritis receiving unilateral primary minimally-invasive surgery of total hip arthroplasty (MIS-THA) performed by the same surgeon at the same hospital

Exclusion Criteria

  • patients with renal or hepatic function impairment which precluded multimodal pain control

Arms & Interventions

ERAS for MIS-THA

Experimental

enhanced recovery after surgery (ERAS) pathway for minimally-invasive surgery of total hip arthroplasty (MIS-THA)

Intervention: ERAS for MIS-THA (Procedure)

conventional MIS-THA

Active Comparator

conventional pathway for minimally-invasive surgery of total hip arthroplasty (MIS-THA)

Intervention: conventional MIS-THA (Procedure)

Outcomes

Primary Outcomes

post-operative length of hospital stay

Time Frame: up to 2 weeks after operation

post-operative length of hospital stay

rate of same-day independent mobilization

Time Frame: up to 24 hours after operation

rate of same-day independent mobilization (ambulation without assistance from another person within 24 hours after operation)

Secondary Outcomes

  • rate of PONV(up to 2 weeks after operation)
  • post-operative analgesics usage(up to 2 weeks after operation)
  • post-operative 1-year EQ-5D index of quality of life(1 year after operation)
  • the rate of blood transfusion(up to 2 weeks after operation)
  • post-operative VAS pain scores(up to 24 hours after operation)
  • post-operative 1-year Harris hip score(1 year after operation)
  • post-operative 1-year Oxford hip score(1 year after operation)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials